Indian herbal medicines: Possible potent therapeutic agents for rheumatoid arthritis

Journal of Clinical Biochemistry and Nutrition

Volumn 41, Issue 1, 2007, Pages 12-17

  Rathore, Brijesh ^a   Mahdi, Abbas Ali ^a   Paul, Bhola Nath ^b   Saxena, Prabhu Narayan ^c   Das, Siddharth Kumar ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c DR B R AMBEDKAR UNIVERSITY   (India)

Author keywords

Alternative medicine; Cytokine; Free radical; Indian herbal; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; AYURVEDIC DRUG; CROCUS SATIVUS EXTRACT; CURCUMA LONGA EXTRACT; ETANERCEPT; FREE RADICAL; GINGER EXTRACT; GLUCOCORTICOID; HERBACEOUS AGENT; INFLIXIMAB; MADIMADI; NONSTEROID ANTIINFLAMMATORY AGENT; NYCTANTHES ARBOR EXTRACT; PINEAPPLE EXTRACT; PLANT EXTRACT; SHIRAIA BAMBUSICOLA EXTRACT; STROBILANTHUS CALLOSUS EXTRACT; SWERTIA CHIRAYITA EXTRACT; TREWIA POLYCARPA EXTRACT; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG;

ACANTHACEAE; ALTERNATIVE MEDICINE; AYURVEDA; BONE INJURY; CELL PROLIFERATION; CROCUS; CURCUMA LONGA; DIET; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG POTENCY; EUPHORBIA; GINGER; HERBAL MEDICINE; HUMAN; INDIA; JASMINE; NONHUMAN; NYCTANTHES ARBOR; PATHOPHYSIOLOGY; PINEAPPLE; REVIEW; RHEUMATOID ARTHRITIS; SHIRAIA BAMBUSICOLA; SWERTIA; SYNOVIOCYTE; TRIPTERYGIUM; TWERIA POLYCARPA; UNSPECIFIED SIDE EFFECT;

EID: 34547949735     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2007002     Document Type: Review

References (45)

1. Arend, W.: The innate immune system in rheumatoid arthritis. Arthritis Rheum., 44, 2224-2234, 2001.
2. David, M. and Weinblatt, M.: Rheumatoid arthritis. Lancet, 358, 903-911, 2001.
3. Gregersen, P.: Genetics of rheumatoid arthritis: confronting complexicity. Arthritis Res., 1, 37-44, 1999.
4. Silman, A., MacGregor, A., Thomson, W., Holligan, S., Carthy, D., Farhan, A., and Ollier, W.: Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol., 32, 903-907, 1993.
5. Soden, M., Rooney, M., Cullen, A., Whelan, A., Feighery, C., and Bresnihan, B.: Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br. J. Rheumatol., 28, 287-292, 1989.
6. Hamilton, J.A.: Hypothesis: In vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J. Rheumatol., 10, 845-851, 1983.
7. Courtenay, J., Dallman, M., Dayan, A., Martin, A., and Mosedale, B.: Immunisation against heterologous type II collagen induces arthritis in mice. Nature, 14, 666-668, 1980.
8. Trentham, D.: Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum., 25, 911-916, 1982.
9. Arend, W. and Dayer, J.: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum., 33, 305-315, 1990.
10. Fang, Y., Yang, S., and Wu, G.: Free radicals, anti-oxidants, and nutrition. Nutrition, 18, 872-879, 2002.
11. Gotia, S., Popovici, I., and Hermeziu, B.: Anti-oxidant enzymes levels in children with juvenile rheumatoid arthritis. Rev. Med. Chir. Soc. Med. Nat. Iasi., 105, 499-503, 2001.
12. Mahdi, A.A.: Free radicals and other anti-oxidants. A text book of biochemistry by SP Singh, 3rd Ed. CBS publishers and distributors, New Delhi, pp. 545-555, 1996.
13. Bauerova, K. and Bezek, A.: Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen. Physiol. Biophys., 18, 15-20, 1999.
14. Mapp, P., Grootveld, M., and Blake, D.: Hypoxia, oxidative stress and rheumatoid arthritis. Br. Med Bull., 51, 419-436, 1995.
15. Hadjigogos, K.: The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med., 45, 7-13, 2003.
16. Halliwell, B.: Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann. Rheum. Dis., 54, 505-510, 1995.
17. Kajanachumpol, S., Vanichapuntu, M., Verasertniyom, O., Totemchokchyakarn, K., and Vatanasuk, M.: Levels of plasma lipid peroxide products and anti-oxidant status in rheumatoid arthritis. Southeast Asian J. Trop. Med. Public Health., 31, 335-338, 2000.
18. Kacsur, C., Mader, R., Ben-Amotz, A., and Levy, Y.: Plasma anti-oxidants and rheumatoid arthritis. HareFuah, 41, 148-150, 2002.
19. Heliovaara, M., Knekt, P., Aho, K., Aaran, R.K., Alfthan, G., and Aromaa, A.: Serum anti-oxidants and risk of rheumatoid arthritis. Ann. Rheum. Dis., 53, 51-53, 1994.
20. Karatas, F., Ozates, I., Canatan, H., Halifeoglu, I., Karatepe, M., and Colakt, R.: Anti-oxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian J. Med. Res., 118, 178-181, 2003.
21. Jaswal, S., Mehta, H., Sood, A., and Kaur, J.: Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin. Chim. Acta., 338, 123-129, 2003.
22. McInnes, I., Leung, B., Field, M., Wei, X., Huang, F., Sturrock, R., Kinninmonth, A., Weidner, J., Mumford, R., and Liew, F.: Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med., 184, 1519-1524, 1996.
23. Moreland, L., Baumgartner, S., Schiff, M., Tindall, E., Fleischmann, R., Weaver, A., Ettlinger, R., Cohen, S., Koopman, W., Mohler, K., Widmer, M., and Blosch, C.: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, N. Eng. J. Med., 337, 141-147, 1997.
24. Moreland, L., Michael, H., Scott, W., Elizabeth, A., Roy, M., Ken, J., Bulpitt, A., Weaver, L., Keystone, E., Furst, D., Mease, P., Ruderman, E., Horwitz, D., Arkfeld, D., Garrison, L., Burge, D., Blosch, C., Lange, M., McDonnell, N., and Weinblatt, M.: Etanercept therapy in rheumatoid arthritis. A randomised, controlled trial. Ann. Intern. Med., 130, 478-486, 1999.
25. Moreland, L.W., Heck, L.W. Jr., and Koopman, W.J.: Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum., 40, 397-409, 1997.
26. Soeken, K., Miller, S., and Ernst, E.: Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology, 42, 652-659, 2003.
27. Ernst, E.: Prevalence of use of alternative medicine: a systematic review. Bull. World Health Organ., 78, 252, 2000.
28. Calder, P.: Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc. Nutr. Soc., 55, 737-774, 1996.
29. rd International Symposium on natural anti-oxidants-molecular mechanisms and health effects (ISNA), Shanghai, China, June 24-29, 2005.
30. Mahdi, A.A., Rathore, B., Chandra, A., Paul, B.N., Singh, R.K., Das, S.K., Bajpai, M., and Chander, R.: Free radicals and anti-oxidants in diabetes and arthritis: possible role of herbal medicines. Book of abstract. International conference on natural products for health and beauty (NPHB), Maha Sarakham, Thailand, October 17-21, 2005.
31. Ueki, Y., Miyake, S., Tominaga, Y., and Eguchi, K.: Increased nitric oxide levels in patients with rheumatois arthritis. J. Rheumatol., 230, 230-236, 1996.
32. Sharma, J., Srivastava, K., and Gan, E.: Suppressive effects of eugenol and ginger oil arthritic rats. Pharmacology, 49, 314-318, 1994.
33. Cohen, A. and Goldman, J.: Bromelain therapy in rheumatoid arthritis. Pennsylvania Med. J., 67, 27-30, 1964.
34. Deodhar, S., Sethi, R., and Srimal, R.: Preliminary study on antirheumatic activity of curcumin. Indian J. Med. Res., 71, 632-634, 1980.
35. Paul, B.N. and Saxena, A.K.: Depletion of TNF-α in mice by Nyctanthes arbortristis. J. Ethnopharmacol., 56, 153, 1997.
36. Kumar, I.V., Paul, B.N., Asthana, A., Saxena, A., Mehrotra, S., and Raj an, G.: Swertia chirayita mediated modulation of IL-1β, IL-6, IL-10, IFN-γ and TNF-α in arthritic mice. Immunopharmacol. Immunotoxicol., 25, 573-583, 2003.
37. Hossein, H. and Younesi, H.: Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacology, 2, 7, 2002.
38. Agarwal, R. and Rangari, V.: Anti-inflammatory and anti-arthritic activities of lupeol and 19α-H lupeol isolated from Strobilanthus callosus and Strobilanthus ixiocephala roots. Ind. J. Pharm., 35, 384-387, 2003.
39. Tao, X.L., Ying, S., and Dong, Y.: A prospective, controlled, double-blind, cross study of Tripterigium wilfodii Hook F in treatment of rheumatoid arthritis. Chin. Med. J., 102, 327-332, 1989.
40. Chamundeeswari, D., Vasantha, J., Gopalakrishnan, S., and Sukumar, E.: Free radical scavenging activity of the alcoholic extract of Trewia polycarpa roots in arthritic rats. J. Ethnopharmacol., 88, 51-56, 2003.
41. Kim, M., Yi, J., Sung, M., Kim, H., Hong, S., and Min, H.: Madimadi, Korean folk medicine, blocks TNF-α, IL-1β, and IL-8 production by activated human immune cells. Cytokines, 25, 179-186, 2004.
42. Hiramitsu, T., Yasuda, T., Ito, H., Shimizu, M., Julovi, S., Kakinuma, T., Akiyoshi, M., Yoshida, M., and Nakamura, T.: Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1 {beta}-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-{kappa} B and p38. Rheumatology (Oxford), 45, 824-832, 2006.
43. Sylvester, J., Liacini, A., Li, W., Dehnade, F., and Zafarullah, M.: Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities. Mol. Pharmacol., 59, 1196-1205, 2001.
44. Tong, Y., Zhang, X., Zhao, W., Zhang, Y., Lang, J., Shi, Y., Tan, W., Li, M., Zhang, Y., Tong, L., Lu, H., Lin, L., and Ding, L.: Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Eur. J. Pharmacol., 494, 101-109, 2004.
45. Yu, F., Yu, F., Li, R., and Wang, R.: Inhibitory effects of the Gentiana macrophylla extract on rheumatoid arthritis of rats. J. Ethnopharmacol., 95, 77-81, 2004.